HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8 | -72.4% | 211 | -73.9% | 0.00% | – |
| Q2 2023 | $29 | +383.3% | 807 | +366.5% | 0.00% | – |
| Q1 2023 | $6 | -97.7% | 173 | -96.2% | 0.00% | -100.0% |
| Q4 2022 | $262 | -95.6% | 4,591 | +3133.1% | 0.00% | – |
| Q3 2022 | $6,000 | -53.8% | 142 | -57.0% | 0.00% | – |
| Q4 2021 | $13,000 | 0.0% | 330 | 0.0% | 0.00% | – |
| Q3 2021 | $13,000 | -13.3% | 330 | 0.0% | 0.00% | – |
| Q2 2021 | $15,000 | -53.1% | 330 | -56.6% | 0.00% | – |
| Q1 2021 | $32,000 | -15.8% | 760 | -15.6% | 0.00% | – |
| Q4 2020 | $38,000 | +11.8% | 900 | -30.8% | 0.00% | – |
| Q3 2020 | $34,000 | -37.0% | 1,300 | -35.0% | 0.00% | – |
| Q2 2020 | $54,000 | -85.6% | 2,000 | -89.6% | 0.00% | -100.0% |
| Q1 2018 | $376,000 | -3.1% | 19,172 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $388,000 | – | 19,172 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,816,162 | $191,226,000 | 8.73% |
| BB BIOTECH AG | 6,825,532 | $65,866,000 | 2.13% |
| Lombard Odier Asset Management (USA) Corp | 2,700,000 | $26,055,000 | 1.79% |
| SECTORAL ASSET MANAGEMENT INC | 3,724,351 | $35,940,000 | 1.61% |
| QVT Financial LP | 2,010,186 | $19,398,000 | 0.97% |
| JHL Capital Group LLC | 1,475,000 | $14,234,000 | 0.94% |
| MAZAMA CAPITAL MANAGEMENT INC | 358,087 | $3,456,000 | 0.79% |
| EcoR1 Capital, LLC | 160,700 | $1,551,000 | 0.78% |
| Alden Global Capital Ltd | 332,500 | $3,209,000 | 0.77% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 7,274,065 | $70,195,000 | 0.65% |